M Cote, I Matias, I Lemieux, S Petrosino, N … - International Journal of Obesity, 2007 - nature.com Plasma 2-AG, but not AEA, levels correlated positively with BMI, waist girth,
IAA measured by computed tomography, and fasting plasma triglyceride and insulin
levels, and negatively with high-density lipoprotein cholesterol and ... Cited by 77 - Related articles - BL Direct - All 4 versions
L Van Gaal, X Pi-Sunyer, JP Després, C … - Diabetes Care, 2008 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—The RIO studies enrolled patients who were either
overweight (BMI >27 kg/m 2 ) with at least one comorbidity (ie, hypertension,
dyslipidemia, or, for RIO-Diabetes, type 2 diabetes) or obese. All patients ... Cited by 68 - Related articles - BL Direct - All 5 versions
- ►endojournals.org C Pagano, C Pilon, A Calcagno, R Urbanet, M … - Journal of Clinical Endocrinology & Metabolism, 2007 - Endocrine Soc Experimental Design: We measured expression of type 1 and type 2 cannabinoid
receptors (CNR), enzymes of cannabinoids synthesis and degradation in human
omental, sc abdominal, and gluteal adipose tissue from lean and obese ... Cited by 34 - Related articles - BL Direct - All 3 versions
LM Ruilope, JP Després, A Scheen, X Pi- … - Journal of Hypertension, 2008 - journals.lww.com Objective: Rimonabant, the first selective cannabinoid type 1 (CB 1 ) receptor
blocker, has been shown to improve multiple cardiometabolic risk factors in
overweight/obese patients. This analysis assessed the impact of rimonabant ... Cited by 32 - Related articles - BL Direct - All 5 versions
GR Hajer, TW van Haeften, FLJ Visseren - European Heart Journal, 2008 - Eur Soc Cardiology The increased prevalence of excessive visceral obesity and obesity-related
cardiovascular risk factors is closely associated with the rising incidence of
cardiovascular diseases and type 2 diabetes mellitus. This clustering of ... Cited by 33 - Related articles - All 4 versions
AA Izzo, M Camilleri - British Medical Journal, 2008 - gut.bmj.com A multitude of physiological effects and putative pathophysiological roles have
been proposed for the endogenous cannabinoid system in the gastrointestinal
tract, liver and pancreas. These range from effects on epithelial growth ... Cited by 28 - Related articles - All 3 versions
KM Starowicz, L Cristino, I Matias, R Capasso … - Obesity, 2008 - nature.com Objective: Reduction of cortisone to cortisol is mediated by 11 -hydroxysteroid
dehydrogenase type 1 (11 HSD1), a putative key enzyme in obesity-related
complications. Experimental studies suggest that adipokines, notably leptin ... Cited by 28 - Related articles - All 2 versions
D Cota - Diabetes/Metabolism Reviews - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 29 - Related articles - BL Direct - All 3 versions
M Lafontan, PV Piazza, J Girard - Diabetes and Metabolism, 2007 - Elsevier Clinical reports (RIO trials) have shown that chronic administration of a
CB-cannabinoid receptor antagonist (rimonabant) provides improvements of
disturbed metabolic parameters observed in overweight and obese patients ... Cited by 24 - Related articles - BL Direct - All 4 versions
